Admission Date:  [**2140-7-27**]              Discharge Date:   [**2140-8-7**]  Date of Birth:  [**2077-6-16**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**Last Name (NamePattern1) 1561**] Chief Complaint: transferred for further management of tracheal stenosis  Major Surgical or Invasive Procedure: Bronchoscopy with stent placement Bronchoscopy   History of Present Illness: 63 y/o F w/hx of breast Ca s/p lumpectomy/chemo [**2135**], who presented to [**Hospital 531**] [**Hospital 63637**] Hospital on [**2140-7-23**] with shortness of breath.
She then went to The Oasis Center in Tijuana, [**Country 149**] in [**Month (only) **] of this year, and was treated with a vaccine of some sort, as well as numerous vitamins.
She was begun on Solumedrol 60 IV q12h and had a CT scan of her chest (r/o PE) and neck (eval for tracheal compression).
She also was placed on ceftriaxone and azithromycin.
She was evaluated by Pulmonary, Thoracic Surgery, ENT, Heme-Onc, and Rad-Onc who all agreed that she needed definitive therapy for her extrinsic tracheal compression and she was transferred to [**Hospital1 18**] for Interventional Pulmonary evaluation on [**7-27**].
s/p cyclophosphamide and Taxol x 6 months in [**2135**].
Had recurrence at left supraclavicular node s/p excision, refused chemo.
Endometrial Ca s/p hysterectomy [**2136**]   Social History: Lives alone in [**State 531**], has 3 children who live nearby.
Physical Exam: T: 99.1  P: 71  BP: 123/56  R: 16  98%RA Gen: alert and oriented pleasant female in no acute distress, but with audible inspiratory stridor and frequent coughing during exam HEENT:  normocephalic, atraumatic, MM dry, anicteric.
Ext: no edema, 2+ distal pulses Skin: warm and dry   Pertinent Results: Labs from OSH:  WBC 9.3 Hct 29.2 Plt 316  Na 138 K 4.4 Cl 103 HCO3 25 BUN 15 Creat 0.5 Glc 121  PT 11 PTT 27 INR 1.0  Ca 8.7 Alb 4.2 Total protein 8 Tot bili 0.3 Alk phos 59 ALT 12 AST 22 LDH 122  CEA 112.4  CXR [**7-24**]:  large superior mediastinal mass with leftward tracheal deviation, no infiltrate  CT neck with contrast [**7-23**]:  extensive bilateral cervical adenopathy up to 4 cm in diameter, some with moderate central necrosis.
Labs on admission: [**2140-7-27**] 05:57PM BLOOD WBC-10.1 RBC-3.71* Hgb-10.7* Hct-32.1* MCV-86 MCH-28.8 MCHC-33.3 RDW-13.0 Plt Ct-334 [**2140-7-27**] 05:57PM BLOOD PT-11.8 PTT-24.0 INR(PT)-0.9 [**2140-7-27**] 05:57PM BLOOD Calcium-9.4 Phos-2.5* Mg-2.0  Labs on discharge: [**2140-8-6**] 06:35AM BLOOD WBC-10.4 RBC-3.78* Hgb-11.3* Hct-33.3* MCV-88 MCH-29.9 MCHC-34.0 RDW-13.3 Plt Ct-404 [**2140-8-5**] 06:30AM BLOOD Glucose-122* UreaN-14 Creat-0.6 Na-140 K-4.5 Cl-104 HCO3-27 AnGap-14  Procedure date     Tissue received     Report Date    Diagnosed by [**2140-8-2**] [**2140-8-2**] [**2140-8-4**] DR. [**Last Name (STitle) **] [**Last Name (NamePattern4) **]/crxs  DIAGNOSIS: Excised soft tissue, "Tracheal tumor versus granulation tissue."
She was admitted to the ICU and went to the OR tomorrow the following day for rigid bronch with placement of a Y stent by the interventional pulmonary staff.
She initiated daily radiation treatments on [**2140-8-1**].
She tolerated radiation treatments well without evidence of stridor or airway compromise.
She underwent repeat bronchoscopy on [**2140-8-2**] which revealed boggy/infiltrate arytenoid with narrow glottis and proximal trachea.
A tissue flap partially occluding the proximal tracheal stent was excised with forceps.
Moderate secretions in the mid-tracheal stent were therapeutically aspirated.
The patient was also continued on IV dexamethasone while undergoing radiation.
The patient is to continue daily radiation therapy to complete a 10 day course.
Radiation oncologists at [**Hospital1 18**] contact[**Name (NI) **] radiation oncology at [**Name (NI) 531**] [**Hospital 63637**] hospital and communicated the treatment plan.
The patient was continued on an aggressive anti-tussive regimen and continued on pain medications prn.
If 3+ HER-2-NEU, then herceptin should be considered as an additional [**Doctor Last Name 360**] in additional to standard chemotherapy after radiation therapy is completed.
Prophylaxis:  The patient was continued on subcutaneous heparin for DVT prophylaxis and stool softeners while on narcotic pain medications.
Medications on Admission: numerous vitamins and herbal supplements  Discharge Medications:  1.
Heparin Sodium (Porcine) 5,000 unit/mL Solution Sig: 5000 (5000) units Injection TID (3 times a day).
Lidocaine HCl 1 % Solution Sig: 2.5 MLs Injection Q1-2H () as needed for cough.
Guaifenesin 100 mg/5 mL Syrup Sig: 5-10 MLs PO Q6H (every 6 hours) as needed for cough.
Benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Zolpidem Tartrate 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed.
Acetaminophen-Codeine 120-12 mg/5 mL Elixir Sig: 12.5-25 MLs PO Q4H (every 4 hours) as needed.
Lansoprazole 30 mg Susp,Delayed Release for Recon Sig: Thirty (30) mg PO DAILY (Daily).
Morphine 2 mg/mL Syringe Sig: Two (2) mg Injection Q4H (every 4 hours) as needed.
Cepacol 2 mg Lozenge Sig: One (1) Lozenge Mucous membrane Q4H (every 4 hours) as needed.
Aluminum-Magnesium Hydroxide 225-200 mg/5 mL Suspension Sig: 15-30 MLs PO TID (3 times a day) as needed.
Albuterol Sulfate 0.083 % Solution Sig: One (1) nebulizer treatment Inhalation Q6H (every 6 hours) as needed.
Dexamethasone 4 mg IV Q6H 15.
Guaifenesin 1,200 mg Tablet Sustained Release 12HR Sig: One (1) tablet PO twice a day as needed for cough.
